ADPT — Adaptive Biotechnologies Corporation
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Adaptive Biotechnologies Corporation (ADPT), worth $17.84M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Essex | $10.14M | 1.30% | -4.2% |
| Renaissance | $6.50M | 0.00% | +26.3% |
| Quadrature | $1.20M | 0.01% | +350.7% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.